Trial Profile
Efficacy and Safety of 200 Mcg QD or 200 Mcg BID Mometasone Furoate Nasal Spray (MFNS) vs Amoxicillin vs Placebo as Primary Treatment of Subjects With Acute Rhinosinusitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Mometasone (Primary) ; Amoxicillin
- Indications Bacterial infections; Sinusitis
- Focus Therapeutic Use
- Sponsors Organon; Schering-Plough
- 27 Sep 2008 New trial record.